BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 8167132)

  • 1. Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. Thoratec Ventricular Assist Device Principal Investigators.
    Farrar DJ
    J Heart Lung Transplant; 1994; 13(1 Pt 1):93-100; discussion 100-1. PubMed ID: 8167132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices. Thoratec Ventricular Assist Device Principal Investigators.
    Farrar DJ; Hill JD
    J Heart Lung Transplant; 1994; 13(6):1125-32. PubMed ID: 7865520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seven years' experience with the Pierce-Donachy ventricular assist device.
    Pennington DG; Kanter KR; McBride LR; Kaiser GC; Barner HB; Miller LW; Naunheim KS; Fiore AC; Willman V
    J Thorac Cardiovasc Surg; 1988 Dec; 96(6):901-11. PubMed ID: 3057290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
    McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thoratec implantable ventricular assist device: the Papworth experience.
    Berman M; Parameshwar J; Jenkins DP; Dhital K; Lewis C; Dempster K; Lincoln P; Sudarshan C; Large SR; Dunning J; Tsui SS
    J Thorac Cardiovasc Surg; 2010 Feb; 139(2):466-73. PubMed ID: 19833355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
    Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device.
    Slaughter MS; Tsui SS; El-Banayosy A; Sun BC; Kormos RL; Mueller DK; Massey HT; Icenogle TB; Farrar DJ; Hill JD;
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1573-80. PubMed ID: 17532959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal timing of cardiac transplantation after ventricular assist device implantation.
    Gammie JS; Edwards LB; Griffith BP; Pierson RN; Tsao L
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1789-99. PubMed ID: 15173738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoratec VAD system as a bridge to heart transplantation.
    Farrar DJ; Lawson JH; Litwak P; Cederwall G
    J Heart Transplant; 1990; 9(4):415-22; discussion 422-3. PubMed ID: 2398438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eleven years' experience with the Pierce-Donachy ventricular assist device.
    Pennington DG; McBride LR; Miller LW; Swartz MT
    J Heart Lung Transplant; 1994; 13(5):803-10. PubMed ID: 7803421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation.
    Dang NC; Topkara VK; Kim BT; Mercando ML; Kay J; Naka Y
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1302-9. PubMed ID: 16256782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of left ventricular assist device support affects transplant survival.
    Ashton RC; Goldstein DJ; Rose EA; Weinberg AD; Levin HR; Oz MC
    J Heart Lung Transplant; 1996 Nov; 15(11):1151-7. PubMed ID: 8956124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
    J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
    J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumatic paracorporeal ventricular assist device in infants and children: initial Stanford experience.
    Malaisrie SC; Pelletier MP; Yun JJ; Sharma K; Timek TA; Rosenthal DN; Wright GE; Robbins RC; Reitz BA
    J Heart Lung Transplant; 2008 Feb; 27(2):173-7. PubMed ID: 18267223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.